Table 1.
Laboratory data.
| Admission to hospital | Before retreatment with dasatinib | 22 days after retreatment | |
|---|---|---|---|
| Peripheral blood samples | |||
| Leukocytes (×102/μL) | 380 | 79 | 78 |
| Neutrophils (%) | 4 | 67 | 65 |
| Lymphocytes (%) | 7 | 28 | 15 |
| Monocytes (%) | 0 | 2 | 7 |
| Blastoid cells (%) | 84 | 0 | 0 |
| Hemoglobin (g/dL) | 7.6 | 9.4 | 8.2 |
| Platelet (×104/μL) | 5.4 | 19.8 | 6.8 |
| Bone marrow samples | |||
| Total nucleated cells (/μL) | 74500 | 11000 | |
| Blastoid cells (%) | 96 | 0.4 | |
| Minor bcr-abl mRNA (copy/μg RNA) | 7.0 × 105 | 7.9 × 103 | |
| Karyotype by G-banding | 46XY, t(9;22)(q34;q11.2) [17/20] |
46XY [20/20] |